EJuice.deals – FDA Warning Letter

The FDA's Center for Tobacco Products issued a Warning Letter to ejuice.deals after reviewing their website and determining that their e-liquid products, specifically "&Milk Donuts e-liquid," are offered for sale or distribution in the United States and are considered tobacco products under the FD&C Act.

The primary violation identified was the sale of &Milk Donuts e-liquid to a person younger than 18 years of age, which constitutes misbranding under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)). This violates 21 C.F.R. § 1140.14(b), which prohibits retailers from selling covered tobacco products, including e-liquid, to individuals under 18. The FDA's investigation confirmed a purchase by a minor.

The letter emphasizes that this is not an exhaustive list of violations and requires immediate correction of the identified violation and similar issues. The company is responsible for ensuring all tobacco products, labeling, and advertising on their website and other media comply with the FD&C Act and FDA regulations. Failure to comply may result in further FDA action, including civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, and/or injunction. Adulterated and misbranded tobacco products imported into the U.S. are subject to detention.

A written